GlassScriptPhysician profile
Garrett Michael Snipes
NPI 1013449941
$11,089.12
in general payments reported to CMS, 2019-2025
9 companies · $8,541 in 2025
The $8,541 reported for 2025 was more than what 94% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $126 · 2023: $408 · 2024: $2,014 · 2025: $8,541.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,970 · Grant: $3,750 · Food and Beverage: $2,342 · Education: $901.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,970.42 |
| Grant | $3,750.00 |
| Food and Beverage | $2,342.05 |
| Education | $900.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $7,877.94 | 2022-2025 | Assurity, Ensite Precision, Ensite |
| Boston Scientific Corporation | $2,527.01 | 2023-2025 | General - Therapies, Watchman Flx, Watchman Access System |
| Medtronic, INC. | $296.10 | 2024-2025 | Micra, Aurora Ev-Icd Mri Surescan |
| Abiomed | $110.99 | 2023 | Impella |
| Astrazeneca Pharmaceuticals LP | $99.95 | 2022 | |
| Biotronik INC. | $98.08 | 2025 | Acticor 7 Vr-T Dx, Amvia Edge, Pamira |
| Heartflow, INC. | $35.42 | 2024 | |
| Amgen INC. | $22.56 | 2024 | |
| Biosense Webster, INC. | $21.07 | 2025 | Carto 3, Smartablatetm System Rf Generator |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Garrett Snipes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.